Next Article in Journal
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
Previous Article in Journal
The Bm86 Discovery: A Revolution in the Development of Anti-Tick Vaccines
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Prophage and Us—Shiga Toxin Phages Revisited

1
Department of Food Microbiology, Institute of Food Science and Biotechnology, University of Hohenheim, 70599 Stuttgart, Germany
2
Departament de Genètica, Microbiologia i Estadística, Universitat de Barcelona, 08028 Barcelona, Spain
*
Author to whom correspondence should be addressed.
Pathogens 2023, 12(2), 232; https://doi.org/10.3390/pathogens12020232
Submission received: 20 January 2023 / Accepted: 31 January 2023 / Published: 2 February 2023
The authors first met in 1998 at the University of Würzburg, Germany, at the Institute of Hygiene and Microbiology, in Helge Karch’s lab, where Herbert Schmidt worked as a PostDoc and Maite Muniesa visited the lab for a postdoctoral research stay to work on phages encoding Shiga toxin 2e (Stx2e) [1]. Since that time, we have been more or less, as much as our university duties allow, connected by Stx-phage research.
Initially described in the early 1980s, Shiga toxin-converting bacteriophages (Stx-phages) have been the subject of numerous publications [2,3]. The ability to produce Stx, the major pathogenicity factor of enterohemorrhagic E. coli (EHEC), seems to be essentially connected to the location of the Shiga toxin genes (stx) in the genome of lysogenic phages, found always in a similar location within the late transcribed region, and upstream of the lysis and capsid genes [4,5,6,7,8,9,10,11]. Stx-phages are double-stranded DNA tailed phages showing a lambdoid or a non-lambdoid genome structure. To the best of our knowledge, stx genes have never been found in other mobile genetic elements other than phages, such as plasmids or pathogenicity islands [12,13,14,15,16]. Although the genetics and function of Stx-phages have been described in many publications, some basic questions remain still open, for example, (1) why are Stx-phages so successful in terms of evolution and spread among E. coli strains? (2) why do Stx-phages occur mainly in enteropathogenic E. coli strains but not, or only accidentally, in others such as extraintestinal pathogenic E. coli (EXPEC), (3) which advantage do EHEC strains have from the lysogenic state carrying single or multiple Stx-phages?
As temperate phages, Stx-phages occupy distinct integration sites in the bacterial host genomes [4]. EHEC bacteria may carry one single or multiple Stx-phages; as far as we know, up to 21 prophages have been counted, and sometimes they are integrated in already resident phages. The lengths and genetic composition of these phages differ enormously, and many are fully functional prophages; moreover, cryptic prophages which have lost parts of their genes can be found [15]. The data of Khan et al. [17] suggested that in incomplete prophages, mostly the genes for the replication, packaging, and release of phage particles have been lost, without them being unable to induce and form functional phage particles. The lysogenic state seems so persistently maintained that it suggests that this association should be advantageous for both the host and the phage [17].
The Stx family consists of two larger groups, Stx1, which is almost identical to Stx of Shigella, and Stx2, with numerous variants [18]. The variants have been successfully spread among E. coli strains, where all known stx variants are found, always encoded in the genome of complete or defective prophages [19,20]. In contrast, stx variants are only randomly found in Shigella and in close relatives such as Serratia marcescens and Citrobacter freundii. The enormous abundance of stx genes in prophages in E. coli strains, which are present in many animals, raises the question of the advantage of stx particularly for E. coli.
In contrast, Stx-prophages were described in Shigella sonnei, but it was initially thought that the stx operon was mainly chromosomally encoded in Shigella dysenteriae [21]. It is now clear that in all cases, the stx genes are also surrounded by prophage sequences, even if these are complete or remnant [22]. While few Stx-prophages are inducible, many Stx-phages have become defective particularly in Shigella spp, [23], leading to the initial incorrect assumption that stx was chromosomally encoded in this genus. Unlike E. coli, it was proposed that all Stx-producing S. dysenteriae 1 derive from a clone that resulted from a single phage-integration event [23]. This original Stx-encoding lambdoid prophage subsequently became defective because of a loss of phage sequences following multiple IS element insertions and IS-mediated rearrangements, which commonly occurs in Shigella [24], and when located close to the stx operon [22], even resulting in the loss of stx.
Taken together, many Shigella strains seem to have received and then lost the stx genes in their evolutionary past. The loss of stx provided advantages to the bacteria for better adaptation to the human hosts, since being a more severe pathogen is not the best strategy for the organism’s long-term survival. Alternatively, the integration, retention, and expression of certain new introduced virulence genes might depend on their interaction between them and the bacterial genomic background [25]. In other hosts, as is the case with intestinal E. coli strains, besides the acquisition of a powerful virulence determinant such as Stx, the presence of Stx-phages seems to enhance the colonization and survival of strains residing in certain environments [26]. In addition to these, other advantages can be envisaged [4], the extent of which is not yet fully elucidated [27]. Perhaps the right genomic background to stably retain and express Stx occurs preferentially in enteropathogenic E. coli, in S. dysenteriae type 1, and less frequently in some non-S. dysenteriae type 1 strains [28]. In contrast, Stx-phages rarely encounter the right background in EXPEC, or in many other Shigella species, despite the fact that some of these are susceptible to being lysogenized by Stx-phages under laboratory conditions [29,30].
In a multitude of STEC serotypes, it is widely known that not only one, but multiple prophages, including more than one Stx-phage, can co-exist [19]. These multiple Stx-phages show a diversity of lysis-lysogeny regulatory systems, but all have in common a conserved lytic system always adjacent to stx genes [20], which guarantees the stx expression during prophage excision.
The lack of phage immunity that suppresses the prevention of superinfection [31], the use of diverse integration sites for different Stx-phages [32], the integration in tandem of two Stx-phages sharing the same attB site [15], and even the recently revealed “prophage-in-prophage” ability, in which a Stx-phage integrates within the attB region present in other prophages, might be the main causes explaining the presence of more than one Stx-phage in a single cell [15]. The pros and cons of carrying more than one Stx-phage are still under discussion, and in the presence of two or more Stx-prophages, some authors propose an enhanced Stx production [16], while others show a down-regulated stx expression [33,34]. In fact, both options might be beneficial for the bacteria. In the case of a higher Stx production, the acceptance of more than one Stx-prophage allows the strain to become more pathogenic. In the case of down-regulated Stx production, the presence of multiple Stx-phages could allow a better survival and a milder pathogenicity that, as discussed above, seems a plausible long-term survival strategy. It is possible that both options can occur, depending on the phage induction levels, the host genetic background and its protein expression capacity, and the environmental factors of the host strain reservoir. It remains unclear, however, if benefits can be derived for the phages co-existing within the same host, other than allowing recombination events between phages that ensure the genetic variability and evolvability of the Stx-phages [20].
Exploring the origin of stx before the original toxin described in S. dysenteriae type 1, Shiga toxins belong to the enzyme group of ribosome-inactivating proteins (RiP) (E.C. 3.2.2.22) and are classified as type 2 RiPs with two chains, consisting of a single enzymatic subunit, connected to five receptor-binding B-subunits. Single-chain type 1 RiPs occur frequently in plants and show antiviral, antifungal, and insecticidal activity [35,36]. Interestingly, the Stx A-subunit shows some homology to one of these RiPs, ricin, and when comparing Stx A-subunit with ricin, both show a similar molecular weight, similar crystal structure, and highly conserved amino acids involved in catalysis [37,38]. These similarities initially pointed towards RiPs as a possible origin of Stx. However, experimental evidence [39] showed that ricin, Stx1, and Stx2 have completely different B subunits and interact differently with ribosomes [40,41,42]. Moreover, other similar proteins, such as abrin, modeccin, volkensin, or viscumin, are examples of RiPs that use the same method of entry and mechanism of action and that, far from having a common ancestor, have probably evolved via convergent evolution [43], a separate evolution resulting in analogous structures. This hypothesis discards a possible relationship between Stx and RiPs, suggesting only that, in nature, organisms independently find the same solutions to solve similar problems.
Research that focuses on the molecular biology, function, and impact of Shiga toxin phages is fascinating and worth continuing. The ecological potential and pathogenicity of EHEC strains resides, besides chromosomal genes, on the function of mobile genetic elements, and among these, Stx-encoding phages, which are not yet well understood. Multi-faceted interdisciplinary research is needed to pave the way for a deeper understanding of this important group of genetic elements, and these old entities appear today as highly topical as ever. The increase in hybrid EHEC/enteroaggregative E. coli strains carrying Stx-phages and expressing Stx and the outbreaks caused by such strains underlines this statement. In this editorial, we intended to open the discussion about these yet unanswered questions, with the hope to highlight the enormous impact of Stx-phages and provide a primer for further Stx-phage research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Muniesa, M.; Recktenwald, J.; Bielaszewska, M.; Karch, H.; Schmidt, H. Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infect. Immun. 2000, 68, 4850. [Google Scholar] [CrossRef]
  2. O’Brien, A.D.; Laveck, G.D.; Thompson, M.R.; Formal, S.B. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J. Infect. Dis. 1982, 146, 763–769. [Google Scholar] [CrossRef]
  3. O’Brien, A.D.; Newland, J.W.; Miller, S.F.; Holmes, R.K.; Smith, H.W.; Formal, S.B. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 1984, 226, 694–696. [Google Scholar] [CrossRef]
  4. Rodríguez-Rubio, L.; Haarmann, N.; Schwidder, M.; Muniesa, M.; Schmidt, H. Bacteriophages of Shiga toxin-producing Escherichia coli and their contribution to pathogenicity. Pathogens 2021, 10, 404. [Google Scholar] [CrossRef]
  5. Herold, S.; Karch, H.; Schmidt, H. Shiga toxin-encoding bacteriophages—Genomes in motion. Int. J. Med. Microbiol. 2004, 294, 115–121. [Google Scholar] [CrossRef]
  6. Allison, H.E. Stx-Phages: Drivers and mediators of the evolution of STEC and STEC-like pathogens. Fut. Med. 2007, 2, 165–174. [Google Scholar] [CrossRef]
  7. Yokoyama, K.; Makino, K.; Kubota, Y.; Watanabe, M.; Kimura, S.; Yutsudo, C.H.; Kurokawa, K.; Ishii, K.; Hattori, M.; Tatsuno, I.; et al. Complete nucleotide sequence of the prophage VT1-Sakai carrying the Shiga toxin 1 genes of the enterohemorrhagic Escherichia coli O157:H7 strain derived from the Sakai outbreak. Gene 2000, 258, 127–139. [Google Scholar] [CrossRef]
  8. Karch, H.; Schmidt, H.; Janetzki-Mittmann, C.; Scheef, J.; Kröger, M. Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages. Mol. Gen. Genet. 1999, 262, 600–607. [Google Scholar] [CrossRef]
  9. Plunkett, G.; Rose, D.J.; Durfee, T.J.; Blattner, F.R. Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J. Bacteriol. 1999, 181, 1767–1778. [Google Scholar] [CrossRef]
  10. Neely, M.N.; Friedman, D.I. Functional and genetic analysis of regulatory regions of Coliphage H-19B: Location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol. Microbiol. 1998, 28, 1255–1267. [Google Scholar] [CrossRef] [Green Version]
  11. Neely, M.N.; Friedman, D.I. Arrangement and Functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin. Gene 1998, 223, 105–113. [Google Scholar] [CrossRef]
  12. Kyle, J.L.; Cummings, C.A.; Parker, C.T.; Quiñones, B.; Vatta, P.; Newton, E.; Huynh, S.; Swimley, M.; Degoricija, L.; Barker, M.; et al. Escherichia coli serotype O55:H7 diversity supports parallel acquisition of bacteriophage at Shiga toxin phage insertion sites during evolution of the O157:H7 lineage. J. Bacteriol. 2012, 194, 1885. [Google Scholar] [CrossRef]
  13. Hayashi, T.; Makino, K.; Ohnishi, M.; Kurokawa, K.; Ishii, K.; Yokoyama, K.; Han, C.G.; Ohtsubo, E.; Nakayama, K.; Murata, T.; et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 2001, 8, 11–22. [Google Scholar] [CrossRef]
  14. Lorenz, S.C.; Gonzalez-Escalona, N.; Kotewicz, M.L.; Fischer, M.; Kase, J.A. Genome sequencing and comparative genomics of enterohemorrhagic Escherichia coli O145:H25 and O145:H28 reveal distinct evolutionary paths and marked variations in traits associated with virulence & colonization. BMC Microbiol. 2017, 17, 183. [Google Scholar] [CrossRef]
  15. Nakamura, K.; Ogura, Y.; Gotoh, Y.; Tetsuya, H. Prophages integrating into prophages: A mechanism to accumulate type III secretion effector genes and duplicate Shiga toxin-encoding prophages in Escherichia coli. PLoS Pathog. 2021, 17, e1009073. [Google Scholar] [CrossRef]
  16. Fogg, P.C.M.; Saunders, J.R.; Mccarthy, A.J.; Allison, H.E. Cumulative effect of prophage burden on Shiga toxin production in Escherichia coli. Microbiology 2012, 158, 488–497. [Google Scholar] [CrossRef]
  17. Khan, A.; Burmeister, A.R.; Wahl, L.M. Evolution along the parasitism-mutualism continuum determines the genetic repertoire of prophages. PLoS Comput. Biol. 2020, 16, e1008482. [Google Scholar] [CrossRef]
  18. Scheutz, F.; Teel, L.D.; Beutin, L.; Piérard, D.; Buvens, G.; Karch, H.; Mellmann, A.; Caprioli, A.; Tozzoli, R.; Morabito, S.; et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J. Clin. Microbiol. 2012, 50, 2951–2963. [Google Scholar] [CrossRef]
  19. Shaaban, S.; Cowley, L.A.; McAteer, S.P.; Jenkins, C.; Dallman, T.J.; Bono, J.L.; Gally, D.L. Evolution of a zoonotic pathogen: Investigating prophage diversity in enterohaemorrhagic Escherichia coli O157 by Long-read sequencing. Microb. Genom. 2016, 2, e000096. [Google Scholar] [CrossRef]
  20. Pinto, G.; Sampaio, M.; Dias, O.; Almeida, C.; Azeredo, J.; Oliveira, H. Insights into the genome aarchitecture and evolution of Shiga toxin encoding bacteriophages of Escherichia coli. BMC Genom. 2021, 22, 366. [Google Scholar] [CrossRef]
  21. Fogolari, M.; Mavian, C.; Angeletti, S.; Salemi, M.; Lampel, K.A.; Maurelli, A.T. Distribution and characterization of Shiga toxin converting temperate phages carried by Shigella flexneri in Hispaniola. Infect. Genet. Evol. 2018, 65, 321–328. [Google Scholar] [CrossRef]
  22. Unkmeir, A.; Schmidt, H. Structural analysis of phage-borne stx genes and their flanking sequences in Shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect. Immun. 2000, 68, 4856. [Google Scholar] [CrossRef]
  23. Greco, K.M.; McDonough, M.A.; Butterton, J.R. Variation in the Shiga toxin region of 20th-century epidemic and endemic Shigella dysenteriae 1 strains. J. Infect. Dis. 2004, 190, 330–334. [Google Scholar] [CrossRef] [PubMed]
  24. Yang, F.; Yang, J.; Zhang, X.; Chen, L.; Jiang, Y.; Yan, Y.; Tang, X.; Wang, J.; Xiong, Z.; Dong, J.; et al. Genome dynamics and dversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res. 2005, 33, 6445. [Google Scholar] [CrossRef]
  25. Escobar-Páramo, P.; Clermont, O.; Blanc-Potard, A.B.; Bui, H.; le Bouguénec, C.; Denamur, E. A specific genetic background Is required for acquisition and expression of virulence factors in Escherichia coli. Mol. Biol. Evol. 2004, 21, 1085–1094. [Google Scholar] [CrossRef]
  26. Saile, N.; Schwarz, L.; Eißenberger, K.; Klumpp, J.; Fricke, F.W.; Schmidt, H. Growth Advantage of Escherichia coli O104:H4 strains on 5-N-Acetyl-9-O-Acetyl neuraminic acid as a carbon source Is dependent on heterogeneous phage-borne NanS-p esterases. Int. J. Med. Microbiol. 2018, 308, 459–468. [Google Scholar] [CrossRef]
  27. Zuppi, M.; Tozzoli, R.; Chiani, P.; Quiros, P.; Martinez-Velazquez, A.; Michelacci, V.; Muniesa, M.; Morabito, S. Investigation on the evolution of Shiga Toxin-converting phages based on whole genome sequencing. Front. Microbiol. 2020, 11, 1472. [Google Scholar] [CrossRef]
  28. Zhi, S.; Parsons, B.D.; Szelewicki, J.; Yuen, Y.T.K.; Fach, P.; Delannoy, S.; Li, V.; Ferrato, C.; Freedman, S.B.; Lee, B.E.; et al. Identification of Shiga-toxin-producing Shigella infections in travel and non-travel related cases in Alberta, Canada. Toxins 2021, 13, 755. [Google Scholar] [CrossRef]
  29. Tozzoli, R.; Grande, L.; Michelacci, V.; Ranieri, P.; Maugliani, A.; Caprioli, A.; Morabito, S. Shiga toxin-converting phages and the emergence of new pathogenic Escherichia coli: A world in motion. Front. Cell Infect. Microbiol. 2014, 4, 80. [Google Scholar] [CrossRef]
  30. Gray, M.D.; Lacher, D.W.; Leonard, S.R.; Abbott, J.; Zhao, S.; Lampel, K.A.; Prothery, E.; Gouali, M.; Weill, F.X.; Maurelli, A.T. Prevalence of Stx-producing Shigella species isolated from french travelers returning from the caribbean: An emerging pathogen with international implications. Clin. Microbiol. Infect. 2015, 21, 765.e9. [Google Scholar] [CrossRef] [Green Version]
  31. Serra-Moreno, R.; Jofre, J.; Muniesa, M. Insertion site occupancy by Stx2 bacteriophages depends on the locus availability of the host strain chromosome. J. Bacteriol. 2007, 189, 6645–6654. [Google Scholar] [CrossRef]
  32. Henderson, S.T.; Singh, P.; Knupp, D.; Lacher, D.W.; Abu-Ali, G.S.; Rudrik, J.T.; Manning, S.D. Variability in the occupancy of Escherichia coli O157 integration sites by Shiga toxin-encoding prophages. Toxins 2021, 13, 433. [Google Scholar] [CrossRef]
  33. Serra-Moreno, R.; Jofre, J.; Muniesa, M. The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J. Bacteriol. 2008, 190, 4722–4735. [Google Scholar] [CrossRef]
  34. Ogura, Y.; Mondal, S.I.; Islam, M.R.; Mako, T.; Arisawa, K.; Katsura, K.; Ooka, T.; Gotoh, Y.; Murase, K.; Ohnishi, M.; et al. The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 Is correlated with the subtypes of toxin-encoding phage. Sci. Rep. 2015, 5, 16663. [Google Scholar] [CrossRef]
  35. Jiménez, P.; Tejero, J.; Cordoba-Diaz, D.; Quinto, E.J.; Garrosa, M.; Gayoso, M.J.; Girbés, T. Ebulin from Dwarf Elder (Sambucus Ebulus L.): A Mini-Review. Toxins 2015, 7, 648. [Google Scholar] [CrossRef]
  36. Stirpe, F. Ribosome-inactivating proteins. Toxicon 2004, 44, 371–383. [Google Scholar] [CrossRef]
  37. Fraser, M.E.; Chernaia, M.M.; Kozlov, Y.v.; James, M.N.G. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat. Struct. Biol. 1994, 1, 59–64. [Google Scholar] [CrossRef]
  38. Katzin, B.J.; Collins, E.J.; Robertus, J.D. Structure of ricin A-chain at 2.5 Å. Proteins Struct. Funct. Bioinf. 1991, 10, 251–259. [Google Scholar] [CrossRef]
  39. Tumer, N.E.; Li, X.P. Interaction of Ricin and Shiga toxins with ribosomes. Curr. Top. Microbiol. Immunol. 2012, 357, 1. [Google Scholar] [CrossRef]
  40. Chiou, J.C.; Li, X.P.; Remacha, M.; Ballesta, J.P.G.; Tumer, N.E. The ribosomal stalk Iis required for ribosome binding, depurination of the rRNA and cytotoxicity of ricin A chain in Saccharomyces cerevisiae. Mol. Microbiol. 2008, 70, 1441. [Google Scholar] [CrossRef] [Green Version]
  41. Chan, Y.S.; Ng, T.B. Shiga Toxins: From structure and mechanism to applications. Appl. Microbiol. Biotechnol. 2016, 100, 1597–1610. [Google Scholar] [CrossRef]
  42. Chiou, J.C.; Li, X.P.; Remacha, M.; Ballesta, J.P.G.; Tumer, N.E. Shiga toxin 1 is more dependent on the P proteins of the ribosomal stalk for depurination activity than Shiga toxin 2. Int. J. Biochem. Cell Biol. 2011, 43, 1792. [Google Scholar] [CrossRef]
  43. Lapadula, W.J.; Sanchez-Puerta, M.V.; Juri Ayub, M. Convergent evolution led ribosome inactivating proteins to interact with ribosomal stalk. Toxicon 2012, 59, 427–432. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Schmidt, H.; Muniesa, M. The Prophage and Us—Shiga Toxin Phages Revisited. Pathogens 2023, 12, 232. https://doi.org/10.3390/pathogens12020232

AMA Style

Schmidt H, Muniesa M. The Prophage and Us—Shiga Toxin Phages Revisited. Pathogens. 2023; 12(2):232. https://doi.org/10.3390/pathogens12020232

Chicago/Turabian Style

Schmidt, Herbert, and Maite Muniesa. 2023. "The Prophage and Us—Shiga Toxin Phages Revisited" Pathogens 12, no. 2: 232. https://doi.org/10.3390/pathogens12020232

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop